Let's talk about men's health: hormones, longevity, and cultural shifts, with Hone CEO Saad Alam
In this episode of Second Opinion, Christina Farr and Luba Greenwood discuss men's health with Saad Alam, co-founder and CEO of Hone Health.
Podcast
Dr. Dean Ornish proved heart disease Is reversible. Now he's doing it with Alzheimer's
What Dr. Dean Ornish is showing the establishment about disease reversal
Why healthcare needs more rule breakers with Jonathan Bush, CEO of Zus Health
Luba Greenwood and Ash Zenooz interview Jonathan Bush. Jonathan is the CEO of a16z-backed Zus Health, Executive Chairman of Firefly Health and a co-founder of Athena Health.
The $1M patient keeping employers up at night w/ Lantern CEO John Zutter & Matt Harmon
In this episode of Second Opinion, Christina Farr is joined by John Zutter, CEO of Lantern, and Matt Harmon, a long time benefits executive who's worked at fortune 100 companies to discuss the rising costs of healthcare, focusing on how large employers are addressing the financial impacts of tre
The $500 billion healthcare problem nobody talks about w/ Mike Desjadon, CEO of Anomaly Health
In this episode of Second Opinion, Christina Farr and Luba Greenwood chat with Mike Desjadon, CEO of Anomaly Health, about the state of American healthcare heading into 2025.
Why healthcare innovation can't wait for politics with Andrea Ippolito, CEO of SimpliFed
Ash Zenooz and Luba Greenwood interview Andrea Ippolito about her extensive career in healthcare spanning academia, government, and the private sector, as well as her current role as founder and CEO of SimpiFed. They discuss the intricacies of government roles, the importance of women's health, and
The biotech reset
Luba Greenwood and Ash Zenooz discuss the evolving biotech landscape, the impact of AI on drug discovery, the importance of using real-world evidence in drug development, and personal motivations for continuing efforts in the biotech field.
Future of American healthcare: post-election with Zeke Emanuel
Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Zeke Emanuel, a prominent oncologist, bioethicist, and influential voice in healthcare to discuss the impact of GLP-1 drugs, healthcare affordability, Trump's appointments, and AI in medicine. The second half of the episode was recorded a
Why healthcare is losing its women CEOs
Christina Farr and Ash Zenooz discuss the recent departures of prominent female CEOs from major healthcare companies and explore why progress in female leadership representation has been challenging in the healthcare industry.
Curing more than disease: Rob Perez's mission to transform communities
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood interview Rob Perez, founder of Life Science Cares, about his work bridging the biotech industry with poverty alleviation efforts.
Stanford Medicine's Dean Dr. Lloyd Minor on the Future of Medical Education
Dr. Lloyd Minor, Dean of Stanford School of Medicine joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss the various transformative advancements and challenges in healthcare.
What digital health needs most: Evidence
In this episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood discuss the integration and evaluation of digital tools in healthcare with guest Caroline Pearson from the Peterson Health Technology Institute.